Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon:
Last week, the U.S. Preventive Services Task Force release their plan for how they will craft the next breast screening guidelines. This week, Diagnostic Imaging takes a look at industry response the announcement and what providers think should factor into creating recommendations around this essential service for women.
For additional coverage on breast screening guidelines, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
In the last 30 years, the incidence of thyroid cancer has rising dramatically, making effective imaging critical to identifying patients who have developed this condition and treating them as early as possible. This week, Diagnostic Imaging will speak with Erin Grady, M.D., associate professor and director nuclear medicine education at Emory University School of Medicine, about the latest in molecular imaging and therapy. Look for coverage later this week.
For additional articles on thyroid cancer, click here.
Gender equality has been a hot topic in radiology for decades as efforts are constantly improving to bring more women into the specialty and break down barriers that prevent career advancement. But, gender discrimination and sexual harassment are still a significant problem. This week, Diagnostic Imaging takes a look at the current state of this problem, highlighting some strategies that various institutions have taken to address these issues.
For additional coverage of gender issues in radiology, click here.
Mammography Study Suggests DBT-Based AI May Help Reduce Disparities with Breast Cancer Screening
December 13th 2024New research suggests that AI-powered assessment of digital breast tomosynthesis (DBT) for short-term breast cancer risk may help address racial disparities with detection and shortcomings of traditional mammography in women with dense breasts.
Mammography News: FDA Grants Expanded 510(k) Clearance for AI-Powered SmartMammo Dx DBT Software
November 29th 2024Originally cleared by the FDA in 2021, the SmartMammo Dx software for digital breast tomosynthesis (DBT) can now be utilized with the Senographe Pristina mammography systems from GE HealthCare.